What other stocks do shareholders of Human Genome Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Human Genome Sciences investors own include Bank of America (BAC) , CEMEX (CX) , Cisco Systems (CSCO) , Citigroup (C) , Beazer Homes USA (BZH) , BlackBerry (BB) , Advanced Micro Devices (AMD) , Alio Gold (ALO) , Allot Communications (ALLT) and Altaba (AABA) .

NASDAQ:HGSI

Human Genome Sciences (HGSI) Stock Price, News & Analysis

→ Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad)

Free HGSI Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Human Genome Sciences alerts:

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

About Human Genome Sciences Stock (NASDAQ:HGSI)

Human Genome Sciences, Inc. (HGS) is a biopharmaceutical company. The Company’s products include BENLYSTA (belimumab) for systemic lupus erythematosus (SLE) and raxibacumab for inhalation anthrax. HGS continues to deliver raxibacumab to the United States Strategic National Stockpile (SNS) for emergency use in treating inhalation anthrax. In addition to the Company’s internal pipeline, it has financial rights to two drugs that GlaxoSmithKline (GSK) has advanced to late-stage development. These include darapladib and albiglutide. A randomized Phase 2 trial is evaluating mapatumumab in combination with Nexavar (sorafenib) for the treatment of advanced hepatocellular cancer. The Company manufactures multiple protein and antibody drugs for use in research, clinical and commercial activities. It produces and purifies these protein and antibody drugs in three process development and manufacturing facilities. In August 2012, GlaxoSmithKline plc acquired HGS.

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

HGSI Stock News Headlines

April 1, 2024 | msn.com

Researchers explore the hagfish genome, reconstruct the early genomic history of vertebrates

February 29, 2024 | msn.com

Becoming human: An ancient genome perspective

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

February 27, 2024 | msn.com

Innovative computational tools provide new insights into the polyploid wheat genome

January 30, 2024 | msn.com

The roles of genes and 3D genome folds in determining health

January 17, 2024 | msn.com

USC Scientists Discover Protein Key to 3D Genome Control and Gene Silencing

January 15, 2024 | msn.com

New research reveals major difference in genomes of American and Chinese chestnut

December 8, 2023 | msn.com

Groundbreaking 'Gnocchi' map reveals hidden secrets of the human genome

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

October 19, 2023 | msn.com

Labour urged to protect UK’s genetic sciences from hostile foreign states

September 6, 2023 | forbes.com

Celera's About-Face

August 9, 2023 | msn.com

The Next Human Genome Challenge

July 19, 2023 | finanznachrichten.de

Autolus Therapeutics plc: Autolus Therapeutics announces appointment of Robert F. Dolski as Chief Financial Officer

July 19, 2023 | stockhouse.com

Autolus Therapeutics announces appointment of Robert F. Dolski as Chief Financial Officer

May 30, 2023 | thestreet.com

Human Genome Hit by Benlysta Sales Worry

May 14, 2023 | msn.com

The Science Of Health: How The New Reference Genome Will Help Understand Link Between Human Genes And Health

May 11, 2023 | msn.com

The Human Genome: Global DNA data gets diversity bump

May 11, 2023 | msn.com

Scientists reveal more inclusive update to human genome

May 10, 2023 | msn.com

Scientists have updated the human genome to make it more equitable and inclusive

May 2, 2023 | washingtonpost.com

A genome project cracks mysteries of evolution — and Balto the superdog

April 24, 2023 | msn.com

Canadian science pioneers’ role in the Human Genome Project shows why it’s crucial to fund research

April 13, 2023 | msn.com

The human genome: The most important map ever produced

March 30, 2023 | msn.com

Local Press: UAE's genome project will benefit the entire Arab world

March 8, 2023 | msn.com

Human genome editing offers tantalizing possibilities – but without clear guidelines, many ethical questions still remain

March 3, 2023 | yahoo.com

Asia’s richest man to enter genetic testing market with $145 kits

February 17, 2023 | bbc.co.uk

The human genome

February 16, 2023 | bbc.com

Why the human genome was never completed

See More Headlines

Receive HGSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Human Genome Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:HGSI
CUSIP: N/A
CIK: 901219
Web: www.hgsi.com
Phone: +1-301-3098504
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

HGSI Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Human Genome Sciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Human Genome Sciences investors own include Bank of America (BAC), CEMEX (CX), Cisco Systems (CSCO), Citigroup (C), Beazer Homes USA (BZH), BlackBerry (BB), Advanced Micro Devices (AMD), Alio Gold (ALO), Allot Communications (ALLT) and Altaba (AABA).

This page (NASDAQ:HGSI) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Human Genome Sciences (HGSI) Stock Price, News & Analysis

About Human Genome Sciences Stock (NASDAQ:HGSI)

HGSI Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

HGSI Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info